Outcome of 360 degrees angle surgery across the spectrum of childhood glaucoma.
Phase 4
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: H401- Open-angle glaucomaHealth Condition 3: H402- Primary angle-closure glaucoma
- Registration Number
- CTRI/2022/12/047910
- Lead Sponsor
- Dr Sushmita Kaushik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. A diagnosed case of childhood glaucoma according to CGRN classification requiring glaucoma surgery
2. Cornea clear enough to visualize angle structures
Exclusion Criteria
1. Patients who have undergone previous surgery for Glaucoma.
2. Patients having cloudy or opaque cornea.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢The decrease in intraocular pressure <br/ ><br>â?¢The decrease in antiglaucoma medications <br/ ><br>â?¢Improvement in visual acuity <br/ ><br>â?¢Complications of surgery <br/ ><br>â?¢Secondary interventions required <br/ ><br>â?¢Improvement in cornea clarity <br/ ><br>â?¢Decrease in corneal thicknessTimepoint: 1 day, 1 week, 1 month, 3 months, and 6 months
- Secondary Outcome Measures
Name Time Method â?¢Improvement in visual acuity <br/ ><br>â?¢Complications of surgery <br/ ><br>â?¢Secondary interventions required <br/ ><br>â?¢Improvement in cornea clarity <br/ ><br>â?¢Decrease in corneal thicknessTimepoint: 1 day, 1 week, 1 month, 3 months, and 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted by GATT in childhood open-angle glaucoma (H401) and primary angle-closure glaucoma (H402)?
How does GATT compare to traditional trabeculotomy in reducing intraocular pressure (IOP) for pediatric glaucoma subtypes?
Which biomarkers predict successful IOP control after GATT in CTRI/2022/12/047910 pediatric glaucoma patients?
What are the long-term adverse events of GATT in CTRI/2022/12/047910 for treating primary angle-closure glaucoma (H402)?
Are there adjunctive drug therapies or surgical innovations that enhance GATT outcomes in childhood glaucoma management?